UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2018-06, Vol.30 (6), p.334-345

2018

Volltextzugriff (PDF)

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design

Clinical oncology (Royal College of Radiologists (Great Britain)), 2024-01, Vol.36 (1), p.e11-e19

2024

Volltextzugriff (PDF)

RADICALS-HD: Reflections before the Results are Known

Clinical oncology (Royal College of Radiologists (Great Britain)), 2022-09, Vol.34 (9), p.593-597

2022

Volltextzugriff (PDF)

The Impact of Clinical Factors on the Development of Late Radiation Toxicity: Results from the Medical Research Council RT01 Trial (ISRCTN47772397)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-11, Vol.23 (9), p.613-624

2011

Volltextzugriff (PDF)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform

Clinical oncology (Royal College of Radiologists (Great Britain)), 2017-12, Vol.29 (12), p.778-786

2017

Volltextzugriff (PDF)

Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-10, Vol.28 (10), p.666-667

2016

Volltextzugriff (PDF)

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

The Lancet (British edition), 2011-12, Vol.378 (9809), p.2104-2111

2011

Volltextzugriff (PDF)

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer — A Multi-Arm Multi-Stage Randomised Controlled Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-10, Vol.20 (8), p.577-581

2008

Volltextzugriff (PDF)

Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2013-05, Vol.25 (5), p.318-320

2013

Volltextzugriff (PDF)

Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)

Clinical oncology (Royal College of Radiologists (Great Britain)), 2008-10, Vol.20 (8), p.582-590

2008

Volltextzugriff (PDF)

A proposed charter for clinical trial data monitoring committees: helping them to do their job well

The Lancet (British edition), 2005-02, Vol.365 (9460), p.711-722

2005

Volltextzugriff (PDF)

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer

Radiotherapy and oncology, 2004-08, Vol.72 (2), p.199-211

2004

Volltextzugriff (PDF)

Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397

International journal of radiation oncology, biology, physics, 2010-03, Vol.76 (3), p.747-754

2010

Volltextzugriff (PDF)

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis

European journal of cancer (1990), 2017-10, Vol.84, p.88-101

2017

Volltextzugriff (PDF)

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

European journal of cancer (1990), 2015-02, Vol.51 (3), p.271-281

2015

Volltextzugriff (PDF)

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

Radiotherapy and oncology, 2016-12, Vol.121 (3), p.431-439

2016

Volltextzugriff (PDF)

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

The Lancet (British edition), 2016-03, Vol.387 (10024), p.1163-1177

2016

Volltextzugriff (PDF)

Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings

European journal of cancer (1990), 2022-01, Vol.160, p.24-60

2022

Volltextzugriff (PDF)

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

The Lancet (British edition), 2018-12, Vol.392 (10162), p.2353-2366

2018

Volltextzugriff (PDF)

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

The Lancet (British edition), 2022-01, Vol.399 (10323), p.447-460

2022

Volltextzugriff (PDF)

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

European journal of cancer (1990), 2019-03, Vol.109, p.36-50

2019

Volltextzugriff (PDF)

Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise

Radiotherapy and oncology, 2012-03, Vol.102 (3), p.347-351

2012

Volltextzugriff (PDF)

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

The Lancet (British edition), 2011-05, Vol.377 (9779), p.1749-1759

2011

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(39)

Sprache

Englisch
(38)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Humans
(32)
Male
(29)
Oncology
(26)
Hematology, Oncology And Palliative Medicine
(15)
Prostatic Neoplasms - Radiotherapy
(14)
Prostate Cancer
(12)
Clinical Trials
(11)
Aged
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Survival
(10)
Tumors
(10)
Female
(9)
Middle Aged
(9)
Prostatic Neoplasms - Drug Therapy
(9)
Prostatic Neoplasms - Pathology
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
General & Internal Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Older Age, Early Symptoms and Physical Function are Associated with the Severity of Late Symptom Clusters for Men Undergoing Radiotherapy for Prostate Cancer

A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design

RADICALS-HD: Reflections before the Results are Known

The Impact of Clinical Factors on the Development of Late Radiation Toxicity: Results from the Medical Research Council RT01 Trial (ISRCTN47772397)

Incorporating Biomarker Stratification into STAMPEDE: an Adaptive Multi-arm, Multi-stage Trial Platform

Response to ‘High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice’, by Tanguay et al

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer — A Multi-Arm Multi-Stage Randomised Controlled Trial

Prostate Radiotherapy for Men with Metastatic Disease: A New Comparison in the STAMPEDE Trial

Accuracy and Reproducibility of Conformal Radiotherapy using Data from a Randomised Controlled Trial of Conformal Radiotherapy in Prostate Cancer (MRC RT01, ISRCTN47772397)

A proposed charter for clinical trial data monitoring committees: helping them to do their job well

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer

Dose–Volume Constraints to Reduce Rectal Side Effects From Prostate Radiotherapy: Evidence From MRC RT01 Trial ISRCTN 47772397

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Lack of consensus identifies important areas for future clinical research: Advanced Prostate Cancer Consensus Conference (APCCC) 2019 findings

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity

Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Parameters for the Lyman Kutcher Burman (LKB) model of Normal Tissue Complication Probability (NTCP) for specific rectal complications observed in clinical practise

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

Aktive Filter

Suchergebnisse filtern